Premium
Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma
Author(s) -
Govoni Verônica Mollica,
Da Silva Tereza Cristina,
Guerra Juliana Mariotti,
Pereira Isabel Veloso Alves,
Queiroga Felisbina Luisa,
Cogliati Bruno
Publication year - 2021
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/vco.12685
Subject(s) - germline , somatic cell , germline mutation , cats , carcinogenesis , exon , biology , mammary gland , gene , breast cancer , cancer research , triple negative breast cancer , neoplasm , basal (medicine) , cancer , brca2 protein , immunohistochemistry , mutation , pathology , genetics , medicine , immunology , endocrinology , insulin
Mammary tumours are the first and third most incident neoplasm in women and cats, respectively. Approximately 85% of feline mammary gland tumours are malignant and aggressive, especially the triple‐negative and HER‐2 + molecular subtypes. Triple‐negative basal‐like feline mammary carcinomas (FMCs) are considered suitable models due to the clinical and morphological similarities with human basal‐like triple‐negative breast cancer (TNBC). In women, TNBC has a poor prognosis and is often associated with mutations in the tumour suppressor genes BRCA1 and BRCA2 . In light of this, the aim of the present investigation was to screen somatic and germline variants of BRCA1 and BRCA2 in nine female cats bearing FMCs . Matched whole blood and FMC samples were obtained for genetic analysis. Additional tumour samples were obtained for histopathological and immunohistochemical evaluation. Genomic DNA was isolated and 27 exonic regions of BRCA1 and BRCA2 genes were amplified and screened by next‐generation sequencing. A somatic variant with high functional impact was found in exon 11 of BRCA2 at a frequency of 4.34% in one FMC‐bearing cat. Four germline variants with moderate impact were detected in three of the nine FMC‐bearing cats and were restricted to exon 9 of BRCA1 . It is concluded that the germline genetic variants found in one‐third of FMC‐bearing animals might be associated with a higher risk of hereditary mammary carcinogenesis.